Source abstract
Abstract
Dispersions of cubic liquid crystalline phases, also known as cubosomes, have shown great promise as delivery vehicles for a wide range of medicines. Due to their ordered structure, comprising alternating hydrophilic and hydrophobic domains, cubosomes possess unique delivery properties and compatibility with both water-soluble and -insoluble drugs. However, the drug delivery mechanism and cubosome interaction with human cells and bacteria are still poorly understood. Herein, we reveal how cubosomes loaded with the human cathelicidin antimicrobial peptide LL-37, a system with high bacteria-killing effect, interact with the bacterial membrane and provide new insights into the eradication mechanism. Combining the advanced experimental techniques neutron reflectivity and quartz crystal microbalance with dissipation monitoring, a mechanistic drug delivery model for LL-37-loaded cubosomes on bacterial mimicking bilayers was constructed. Moreover, the cubosome interaction with Escherichia coli was directly visualized using super-resolution laser scanning microscopy and cryogenic electron tomography. We could conclude that cubosomes loaded with LL-37 adsorbed and distorted bacterial membranes, providing evidence that the peptide-loaded cubosomes function as an antimicrobial unit.
Source: openalex_inverted_index · Quality: baseline
Affiliations
RISE Research Institutes of Sweden, Borås 501 15, Sweden
Department of Chemistry and Chemical Engineering, Chalmers University of Technology, Göteborg 412 96, Sweden
Department of Pharmacy, University of Copenhagen, København 2100, Denmark
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden
Rutherford Appleton Laboratory, Didcot OX11 0DE, United Kingdom
Funding
FP7 Nanosciences, Nanotechnologies, Materials and new Production Technologies · LEO Foundation Center for Cutaneous Drug Delivery, University of Copenhagen · RISE Research Institutes of Sweden